In the spring of 2021, as Europe's vaccination campaigns confronted their first serious crisis of public confidence, a familiar tension in modern medicine came into sharp relief: the difference between correlation and causation, between precaution and panic. Several countries paused the AstraZeneca rollout over blood clot reports, while the WHO urged continuation and medical voices like Dr. Hilary Jones argued the data showed no elevated risk — only the ordinary background noise of a condition that afflicts millions regardless of vaccination. The episode was less a story about a vaccine than a
Dr Hilary: No causal link between AstraZeneca vaccine and blood clots
Blood clots are very common anyway, they happen all the time
Mark
When Dr. Jones says the clot rate is actually lower after vaccination, what's he really measuring? Is he comparing vaccinated people to unvaccinated people, or just looking at the raw numbers?
Mimi
He's comparing the observed clot rate in vaccinated people to what you'd expect to see in that same population if they hadn't been vaccinated—the baseline rate. Blood clots happen constantly in the general population. So the question isn't "do any vaccinated people get clots?" It's "are vaccinated people getting clots at a higher rate than unvaccinated people would?"
Mark
But if countries are suspending the vaccine, doesn't that suggest the signal is real, even if it's not causal?
Mimi
It suggests the signal is worth investigating, which is exactly what Jones says. But investigation and suspension are different things. Suspension says "we think this is dangerous." Investigation says "we're not sure yet, so we're being careful." The countries pausing were being cautious, but that caution doesn't prove harm.
Mark
What about the people who got clots after the vaccine? Are they just coincidence?
Mimi
Some of them, yes. That's the hard part. If you vaccinate millions of people, thousands will develop clots in the following weeks simply because clots are common. You can't tell which ones would have happened anyway and which ones were caused by the vaccine without looking at the rate across the whole population.
Mark
So how does the public trust a vaccine when they're hearing about clots and suspensions?
Mimi
That's the real problem Jones can't solve in a television interview. The data might be reassuring, but the headline—"Countries suspend vaccine"—is louder than the explanation. Once doubt is planted, facts alone don't always uproot it.
Le Pouls
- The Netherlands and Ireland joined Norway in suspending the AstraZeneca vaccine, sending a tremor of doubt through one of the world's most critical public health efforts.
- Reports of blood clots in recipients — however statistically ambiguous — were enough to fracture public confidence at a moment when trust was the most precious resource in the pandemic response.
- Dr. Hilary Jones pushed back on live television, arguing that clot rates among the vaccinated were no higher than baseline population rates, and that consistency across age, gender, and batch pointed to coincidence rather than causation.
- The WHO stood firm in recommending continued use, while investigations across Europe proceeded as a precautionary measure — surveillance systems functioning as designed, even as the optics complicated the rollout.
- Host Susanna Reid's quiet disclosure — that she intended to keep her own vaccination appointment — captured the personal calculus millions were quietly performing in real time.
In the spring of 2021, as Europe's vaccination campaigns confronted their first serious crisis of public confidence, a familiar tension in modern medicine came into sharp relief: the difference between correlation and causation, between precaution and panic. Several countries paused the AstraZeneca rollout over blood clot reports, while the WHO urged continuation and medical voices like Dr. Hilary Jones argued the data showed no elevated risk — only the ordinary background noise of a condition that afflicts millions regardless of vaccination. The episode was less a story about a vaccine than about how societies weigh evidence against fear when the stakes are highest.
In mid-March 2021, as Covid vaccination campaigns accelerated across Europe, a wave of precautionary suspensions threatened to undermine one of the rollout's central pillars. The Netherlands joined Ireland in pausing the Oxford-AstraZeneca vaccine over reports of blood clots in recipients, following similar concerns raised in Norway. The moves were cautious by design — but their signal to the public was difficult to contain.
Into that uncertainty stepped Dr. Hilary Jones on Good Morning Britain, offering a measured but firm counterargument. There was no causal link between the vaccine and blood clots, he said. The WHO had already backed continued use, and the data, if anything, suggested clot rates among vaccinated people were lower than baseline population rates — not higher.
Jones anchored his case in epidemiological reality: blood clots are common. They arise from contraceptives, surgery, immobility, and countless other causes. When millions of people are vaccinated, some will inevitably develop clots — because clots happen constantly in any large population. The meaningful question was whether vaccination elevated that rate. Across age groups, genders, countries, and vaccine batches, the numbers held steady. That consistency, Jones argued, pointed to coincidence, not causation.
He did not dismiss the precautionary suspensions — investigation was appropriate, and the surveillance systems were working as intended. But he drew a line between warranted vigilance and unwarranted alarm, a distinction the data, in his reading, clearly supported.
Susanna Reid then offered something more personal: she had booked her own vaccination for that week and planned to go ahead. The evidence, she said, was overwhelming in the vaccine's favour. It was a quiet moment that reflected the private calculations millions were making simultaneously.
What the studio exchange could not resolve was the harder problem beneath it — how public health authorities rebuild confidence once doubt has been seeded, and how ordinary people are expected to distinguish a genuine safety signal from the statistical background noise of a condition that was always there.
In mid-March 2021, as vaccination campaigns accelerated across Europe, a shadow of doubt began to spread. The Netherlands joined Ireland in pausing the rollout of the Oxford-AstraZeneca vaccine, citing reports of blood clots in recipients. Norway had flagged similar concerns. The moves were cautious, precautionary—but they sent a signal that something might be wrong with one of the world's most widely distributed Covid vaccines. Into this moment of uncertainty stepped Dr. Hilary Jones, a prominent medical voice on British television, to make a counterargument that would shape how millions understood the risk.
Appearing on Good Morning Britain, Jones was direct: there was no causal link between the AstraZeneca jab and blood clots. The World Health Organisation, he noted, had already backed the vaccine and recommended its continued use. The data, he insisted, actually pointed in the opposite direction—the rate of blood clots among vaccinated people appeared lower than baseline rates in the general population, not higher.
Jones grounded his argument in a simple epidemiological fact: blood clots are common. They occur naturally all the time, for many reasons. Women taking oral contraceptives face elevated clot risk. Trauma to the body, surgery, immobility—all trigger clotting. Thousands of people suffer heart attacks and strokes each year as a result of blood clots. The background hum of clotting events is constant and substantial. When a vaccine rollout begins, some recipients will inevitably develop clots, simply because clots happen. The question was not whether clots would occur, but whether they occurred at a higher rate than expected.
Here, Jones said, the evidence was reassuring. The investigations underway in Norway, Ireland, and across EU countries and the UK were appropriate and necessary—the surveillance systems worked as they should. But the data collected so far showed no elevation in clot rates. The numbers held steady across age groups, across genders, across different batches of vaccine, across different countries. Consistency across all these variables suggested coincidence, not causation. The pattern you would expect to see if clots were simply happening at their normal rate, not being triggered by the vaccine itself.
Jones acknowledged the legitimacy of the precautionary approach. It was right to investigate, right to look closely, right to maintain vigilance. But he drew a distinction between appropriate caution and unwarranted alarm. The data did not support the latter.
Host Susanna Reid, sitting across from Jones, then disclosed something personal. She had booked her own vaccination for that week and intended to go through with it. She was reluctant to share medical details publicly, she said, but the evidence was overwhelming: the vaccine would save lives. The calculus, for her, was clear.
What neither Jones nor Reid could fully address in that studio moment was the deeper challenge facing public health authorities: how to maintain trust in a vaccine when some countries are suspending it, when reports of adverse events are circulating, when the average person cannot easily distinguish between a genuine safety signal and statistical noise. The investigations would continue. The data would accumulate. But the damage to confidence, once done, is not easily repaired.
Citations marquantes
There is no causal link between the vaccine and blood clots, and the level of blood clots is lower than it would be before vaccinations— Dr. Hilary Jones, Good Morning Britain
The overwhelming evidence is that it is going to save lives— Susanna Reid, on her decision to proceed with vaccination
Envie de l'histoire complète ?
Lire l'original sur Irish Mirror ↗
Health & Medicine